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PREFACE AND AKNOWLEDGEMENTS 
 
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disorder with increasing 
prevalence, morbidity and mortality. It is characterized by non-reversible airflow 
limitation, which can be accompanied by several systemic manifestations. Progressive 
dyspnea, exercise limitation, muscle cachexia and frequent hospitalizations due to 
exacerbations, are only some of the consequences of COPD, particularly when the disease 
is advanced, that need to be addressed with specific treatments. Thus, further 
enlightenment of potential pathophysiologic mechanisms underlying COPD manifestations 
might provide valuable information in this direction. The current study was conducted 
under this scope, as part of a dissertation for the Master Program “Exercise and Health”, 
for the University of Thessaly. The aim of the study was to investigate potential 
associations between emphysema distribution, which reflects the variability of pathologic 
presentation of the disease and dynamic hyperinflation, a physiologic parameter which 
reflects abnormalities in lung and chest mechanics and is particularly related to exertional 
dyspnea and limited functional capacity. 
This dissertation comprises of three parts. The first part, the introduction, consists of two 
smaller sections. The first section is a relatively short but concise discussion on the 
definition, diagnosis, epidemiology and pathologic abnormalities of COPD, emphasizing 
on the variability of emphysema manifestation and distribution. The second section is an 
overview of lung hyperinflation. Its definition, measurement and natural history are 
described, while the pathophysiologic mechanisms of dynamic hyperinflation development 
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are given in more detail. This part ends with the primary and alternative study hypotheses, 
which were tested in the current dissertation.  
The second part is a literature review regarding the association between emphysema 
distribution and several clinical and physiologic parameters in COPD. The four most 
relevant studies are being discussed with strengths and limitations commended. As it is 
concluded, data on the field are scarce and currently no study has evaluated the impact of 
emphysema distribution on dynamic hyperinflation and maximum exercise capacity among 
COPD patients, which constitutes the aim of the current dissertation. 
Finally, the third part describes in detail the exact study protocol and its results. The 
recruitment of study population with inclusion and exclusion criteria, the primary and 
secondary variables measured and the measurement techniques used, the statistical analysis 
applied and the study results are presented in detail. The last section of this part is the 
discussion where the results, the strengths and limitations of the study are discussed and 
future potential applications of the findings are proposed. 
I would really like to thank my supervisor Associate Professor Athanasio Jamurta from the 
department of Physical Education and Sports Science of University of Thessaly for our 
very good cooperation not only during the preparation of this thesis, but also during my 
attendance at the postgraduate course. Without his understanding and his unwavering 
confidence in my face regarding the data collection and the drafting of the thesis during my 
fellowship at the Respiratory Biomedical Research Unit of Royal Brompton Hospital in 
London, this dissertation could not have been completed. 
I would also really like to thank Dr Michael Polkey, Professor of Respiratory Medicine at 
Royal Brompton Hospital in London and Dr Nicholas Hopkinson, Lecturer of Respiratory 
Medicine at Imperial College and Royal Brompton Hospital in London for giving me the 
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amazing chance to work with them at the Respiratory Biomedical Research Unit (BRU) at 
Royal Brompton Hospital. My fellowship there was a once-in a lifetime experience which 
significantly increased my skills both as a researcher and as a respiratory physician. I was 
really lucky to work with two experts in the area of COPD and to have the opportunity to 
participate in several projects carried out in the BRU, apart from the one used for my 
dissertation. I am really grateful for their contribution in defining the purpose of the current 
study and allowing me to use the BRU resources for its completion. I really hope that my 
fellowship there was just the beginning of a collaboration that will continue in the future.  
Finally, I would like to acknowledge Dr Zaid Zoumot, consultant of Respiratory medicine 
and Miss Claire Davey, research physiotherapist at Royal Brompton Hospital for their 
valuable help in patient selection and exercise data collection. I am also grateful to Dr 
Arjun Nair, senior registrar in Radiology and Dr David Hansell, Professor of Radiology in 
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ABSTRACT (300 words) 
Backrgound: Lung hyperinflation, a hallmark of Chronic Obstructive Pulmonary Disease 
(COPD), is the result of airflow limitation and emphysematous parenchymal destruction 
and is associated with dyspnea and exercise limitation. No study has yet evaluated the 
impact of emphysema distribution on dynamic hyperinflation (DH) and maximal exercise 
capacity among COPD patients. 
Aim: To identify: a) the differences in the degree of DH during maximum cardiopulmonary 
exercise testing (CPET) between COPD patients with heterogeneous and matched COPD 
patients with homogeneous emphysema and b) the associations between emphysema 
distribution and CPET parameters in the two patient groups. 
Material-Methods: Data on COPD patients who underwent thorax high-resolution 
computed tomography, full lung function measurements and CPET were retrospectively 
analysed. Resting inspiratory capacity (rIC) was calculated by averaging 4 resting IC 
maneuvers. ΔIC was calculated by subtracting the IC measured during the last 30 seconds 
of maximum exercise (peak IC), from rIC and was expressed as % percentage of rIC 
(ΔIC%). Emphysema quantification was conducted at 3 predefined levels for each patient 
using the syngo PULMO-CT (Siemens AG); a difference >25% between best and worse 
slice defined heterogeneous emphysema. Student’s t-test was used for group comparison, 
after normality of distribution was assessed; level of p<0.05 was considered significant. 
Results: Fifty patients who presented with heterogeneous (62.7% male; 60.9±7.5 years old; 
FEV1%=32.4±11.4; TLCOc%=34.1±10) and 14 with homogeneous emphysema (61.5% 
male; 62.5±5.9 years old; FEV1%=28.1±10.3; TLCOc%=33.3±11.5) fulfilled the 
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enrolment criteria. The two patient groups were matched for all baseline variables tested. 
ΔIC% was significantly higher among patients with homogeneous emphysema (39.8±9.8 
vs.31.2±13, p=0.031), while no other CPET parameter was different between the groups. 
The presence of heterogeneity correlated positively with peak VO2/HR %predicted, peak 
VO2 %predicted and peak respiratory rate, and negatively with ΔIC%. 
Conclusion: Homogeneous emphysema is associated with more DH during maximum 
exercise in COPD patients. 
 
 Keywords:  
Chronic Obstructive Pulmonary Disease; 
Dynamic Hyperinflation;  
Emphysema Distribution; 
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Υπόβαθρο: Η πνευμονική υπερδιαταση, συνέπεια του περιορισμού της εκπνευστικής ροής 
και των εμφυσηματικών αλλοιώσεων του πνεύμονα στη Χρόνια Αποφρακτική 
Πνευμονοπάθεια (ΧΑΠ), σχετίζεται με δύσπνοια και μειωμένη ικανότητα άσκησης. 
Ωστόσο καμμία μελέτη δεν έχει διερευνήσει την επίδραση της κατανομης του 
εμφυσήματος στη δυναμική υπερδιάταση (ΔΥ) και τη μέγιστη ικανότητα για άσκηση των 
ασθενών με ΧΑΠ. 
Σκοπός: Να διερευνηθούν: α) οι διαφορές στο βαθμό ΔΥ κατά την μέγιστη 
καρδιοαναπνευστική δοκιμασία άσκησης (ΚΑΔΑ) μεταξύ ασθενών με ετερογενές και 
όμοιων ασθενών με ομοιογενές εμφύσημα και β) οι συσχετίσεις ανάμεσα στην κατανομή 
του εμφυσήματος και της παραμέτρους της ΚΑΔΑ στις δύο ομάδες. 
Υλικό-Μέθοδοι: Στην αναδρομική μελέτη εντάχθηκαν ασθενείς με ΧΑΠ που υποβλήθηκαν 
σε αξονική τομογραφία θώρακος υψηλής ευκρίνειας, πλήρη έλεγχο αναπνευστικής 
λειτουργίας και μέγιστη ΚΑΔΑ. Η εισπνευστική χωρητικότητα ηρεμίας (rIC) 
υπολογίστηκε από τον μέσο όρο 4 προσπαθειών ηρεμίας. Το ΔIC υπολογίστηκε 
αφαιρώντας την μέγιστη IC, δηλαδή την μετρούμενη στα τελευταία 30 δευτερόλεπτα της 
μέγιστης άσκησης από την rIC και εκφράστηκε ως % αναλογία της rIC (ΔIC%). Η 
ποσοτικοποίηση του εμφυσήματος έγινε σε 3 προκαθορισμένα επίπεδα για κάθε ασθενή με 
το syngo PULMO-CT (Siemens AG). Η διαφορά>25% μεταξύ καλύτερης και χειρότερης 
τομής όρισε το ετερογενές εμφύσημα. Χρησιμοποιήθηκε το Student’s t-test για συγκρίσεις 
μεταξύ των ομάδων, έπειτα από εκτίμηση της κανονικότητας της κατανομής των 
μεταβλητών. Επίπεδο p<0.05 ορίστηκε ως σημαντικό. 
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Αποτελέσματα: Πενήντα ασθενείς με ετερογενές (60.9±7.5 ετών με FEV1%=32.4±11.4 και 
TLCOc%=34.1±10) και 14 με ομοιογενές εμφύσημα (62.5±5.9 ετών με FEV1%=28.1±10.3 
και TLCOc%=33.3±11.5) πληρούσαν τα κριτήρια εισαγωγής. Οι δύο ομάδες ασθενών 
ήταν όμοιες για το σύνολο των παραμέτρων ηρεμίας. Η ΔIC% ήταν σημαντικά υψηλότερη 
στους ασθενείς με ομοιογενές εμφύσημα (39.8±9.8 vs.31.2±13, p=0.031), ενώ καμμία 
άλλη παράμετρος της ΚΑΔΑ δε διέφερε μεταξύ των ομάδων. Η παρουσία ετερογένειας 
συσχετίζονταν θετικά με τις peak VO2/HR %predicted, peak VO2 %predicted και τη 
μέγιστη αναπνευστική συχνότητα και αρνητικά με την ΔIC%. 
Συμπέρασμα: Το ομοιογενές εμφύσημα συνοδεύεται από μεγαλύτερη ΔΥ κατά τη διάρκεια 
μέγιστης άσκησης σε ασθενείς με ΧΑΠ. 
 
 Λέξεις-κλειδιά:  
Χρόνια Αποφρακτική Πνευμονοπάθεια 
Δυναμική Υπερδιάταση 
Κατανομή του εμφυσήματος 
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A. Chronic Obstructive Pulmonary Disease 
Definition, diagnosis and classification of severity 
According to a working definition of Global Initiative for Chronic Obstructive Lung 
Disease (GOLD), Chronic Obstructive Pulmonary Disease (COPD) is a preventable and 
treatable disease with some significant extrapulmonary effects that may contribute to the 
severity in individual patients. Its pulmonary component is characterized by airflow 
limitation that is not fully reversible. The airflow limitation is usually progressive and 
associated with an abnormal inflammatory response of the lung to noxious particles or 
gases.(Global Initiative for Chronic Obstructive Lung Disease, 2014) 
The chronic airflow limitation characteristic of COPD is caused by a mixture of small 
airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), the 
relative contributions of which vary from person to person. The presence and severity of 
airflow limitation is best evaluated with spirometry, which is the most widely used test for 
lung function assessment.(Global Initiative for Chronic Obstructive Lung Disease, 2014)   
COPD may be present in any individual who has been exposed to risk factors for COPD, 
and is manifesting or not relevant symptoms (cough, sputum and/or dyspnea).(Celli, 
MacNee, & ATS/ERS Task Force, 2004) However, a definite COPD diagnosis is made by 
spirometric rather than clinical criteria. According to GOLD and American Thoracic 
Society (ATS) / European Respiratory Society (ERS) guidelines, a ratio of Forced 
Expiratory Volume in 1 second (FEV1) to Forced Vital Capacity (FVC) < 0.7 post 
bronchodilation is the essential criterion to confirm the presence of not fully reversible 
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airflow obstruction.(Celli et al., 2004)(Global Initiative for Chronic Obstructive Lung 
Disease, 2014) 
A large population study indicated that the use of the post bronchodilation FEV1/FVC ratio 
was higher than 0.7 in all age groups, supporting its use as a diagnostic 
criterion.(Johannessen et al., 2006) However, it has been suggested that the use of a fixed 
ratio may result to overdiagnosis of COPD in the elderly, due to the aging process of the 
lung and to the underdiagnosis of COPD in adults younger than 45 years old.(Celli, 
Halbert, Isonaka, & Schau, 2003; Cerveri et al., 2008) Using the lower limit of normal 
(LLN) values for the FEV1/FVC ratio, based on the normal distribution of values, and 
classifying the bottom 5% as abnormal, is one way to correct potential misclassifications. 
Practically, all programmable spirometers could do this calculation if reference equations 
for the LLN values of FEV1/FVC ratio were available.(Cerveri et al., 2008; Global 
Initiative for Chronic Obstructive Lung Disease, 2014) 
The typical symptoms of COPD are cough, sputum and dyspnea; nevertheless the 
association between the severity of airflow limitation and the presence of symptoms is 
imperfect. Cough and sputum could precede airflow limitation for many years, and airflow 
limitation could be present with minimal symptoms.(Global Initiative for Chronic 
Obstructive Lung Disease, 2014) Thus, the categorization of disease severity based on 
spirometric criteria is a pragmatic approach, useful for practical implementation. 
According to ATS/ERS and GOLD guidelines, COPD severity is classified in four 
stages:(Celli et al., 2004)(Global Initiative for Chronic Obstructive Lung Disease, 2014) 
a) Stage I or mild COPD (FEV1/FVC <0.7; FEV1≥80% predicted) where symptoms of 
airflow obstruction are often not present  
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b) Stage II or Moderate COPD (FEV1/FVC <0.7; 50%≥FEV1%predicted<80%). In this 
stage cough and sputum might be present and dyspnea typically develops during exercise 
c) Stage III or Severe COPD (FEV1/FVC <0.7; 30%≥FEV1%predicted<50%). In this stage 
dyspnea is typically more severe, sputum and cough are present most of the time and 
patients present with limited exercise capacity, fatigue and repeated exacerbations 
d) Stage IV or Very Severe COPD (FEV1/FVC <0.7; FEV1%predicted<30% or 
30%≥FEV1%predicted<50% plus chronic respiratory failure). Respiratory failure is 
defined as an arterial partial pressure of oxygen (PaO2) less than 8.0 kPa (60 mm Hg), with 
or without arterial partial pressure of carbon dioxide (PaCO2) greater than 6.7 kPa (50 mm 
Hg) while breathing air at sea level. At this stage quality of life is severely impaired and 
exacerbations could be life-threatening 
COPD aetiology and burden 
Cigarette smoking is the most commonly encountered risk factor for the development of 
COPD worldwide. In USA 80-90% of COPD cases are attributed to smoking(Senior & 
Atkinson, 2008) and previous studies have indicated that there is a causal association 
between cigarette smoking and COPD development.(Office of the Surgeon General (US) 
& Office on Smoking and Health (US), 2004) However, the use of biomass fuel for heating 
and cooking in poorly ventilated rooms is becoming a major risk factor for COPD 
development, mainly among non-smoking women in developing countries.(Salvi & 
Barnes, 2009) Apart from tobacco and biomass exposure, several other risk factors, related 
either to the “host” or the environment have been identified and are presented in Table 1.  
COPD development is the final result of the cumulative exposure to one or more risk 
factors over a period of decades.(Siafakas et al., 1995; Global Initiative for Chronic 
Obstructive Lung Disease, 2014) 
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Table 1. Risk factors for the development of COPD 
Risk factors related to the host 
Age 
Gender 
Genes (e.g. alpha1 deficiency) 
Risk factors related to the environment 
Exposure to particles and fumes 
-tobacco smoking 
-indoor air pollution from heating and cooking with biomass  
-occupational organic and inorganic dust 
-outdoor air pollution 
Lung growth and development 
Oxidative stress 
Respiratory Infections 




COPD is a major health problem worldwide with substantial social and economic burden. 
Of all the major chronic diseases, COPD is the one whose burden is rising fastest, and it is 
now the third leading cause of death worldwide.(Lozano et al., 2012) Both its prevalence 
and burden are going to increase in the future,(Mathers & Loncar, 2006) due to the 
growing exposure to major risk factors and particularly cigarette smoking and because of 
the increasing age of the world population. The increase of age can impact the prevalence 
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of COPD in two ways: the population is exposed to COPD risk factors for more years and 
lives longer to manifest the symptoms and signs of the disease. Moreover, aging itself 
induces several lung parenchymal changes that resemble COPD.(Maciewicz, Warburton, 
& Rennard, 2009) 
The exact prevalence of COPD varies between studies and countries, not only due to the 
unique characteristics of the population investigated, but also because of the discrepancy in 
diagnostic criteria and research tools used, (van den Boom et al., 1998; Halbert, Isonaka, 
George, & Iqbal, 2003) so results are not easily comparable. The Third National Nutrition 
and Examination Survey (NANHES III) indicated that 13.9% of adult population in USA 
suffers from COPD.(Mannino & Braman, 2007) The multicentre Latin American Project 
for the Investigation of Obstructive Lung Disease (PLATINO) which was conducted in 
Central and Latin America reported a COPD prevalence which varied between sites from 
7.8% to 19.4%.(Menezes et al., 2005) In Europe, a population study conducted in Northern 
Italy reported a COPD prevalence of 18.3%,(Viegi et al., 2000) although the frequency of 
COPD varies hugely between countries. Beyond these variations, it has been estimated that 
COPD is the major cause of death from respiratory diseases in Europe.(Viegi et al., 2007)  
COPD pathology and pathophysiology 
Cigarette smoking, biomass fuel and/or other of toxic particles inhalation lead to airway 
inflammation. This normal defensive mechanism of the host is abnormally amplified in 
patients with COPD, may result in abnormal mucus hypersecretion (chronic bronchitis), 
tissue destruction (emphysema), and destruction of normal repair and defense mechanisms, 
causing small airway inflammation and fibrosis (bronchiolitis). These pathologic changes 
result in increased resistance to airflow, particularly in the small conducting airways and 
increased compliance of the lungs, resulting to air trapping and progressive airflow 
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obstruction.(MacNee, 2008) Similar to other chronic inflammatory conditions, the role of 
cytokines in the development of this pathology is major, although not fully 
clarified.(Global Initiative for Chronic Obstructive Lung Disease, 2014)(Barnes, 2009) The 
complex pathologic features of COPD could be grouped in three entities: chronic 
bronchitis, small airways disease and emphysema. In an individual COPD patient these 
three pathologic components coexist to varying degrees and contribute distinctively to the 
abnormalities in lung function, chest wall mechanics and gas exchange.(Russi, Bloch, & 
Weder, 1999) 
Chronic bronchitis is a disease of the larger airways (>2-4 mm) characterized by bronchial 
gland enlargements and chronic mucus hypersecretion.(Russi et al., 1999; MacNee, 2008) 
Mucus is produced by mucus glands in the larger airways and by goblet cells in the airway 
epithelium. In healthy subjects the number of goblet cells is decreased from central to 
peripheral airways, while these cells are totally absent in terminal bronchioles. By contrast, 
in smokers and COPD patients the mean number of golblet cells is increased and they are 
found more peripherally. Moreover, the mucocilliary escalator is impaired and squamous 
metaplasia of the airway epithelium along with increased smooth muscle and connective 
tissue is found in bronchial biopsies.(MacNee, 2008) Small airways disease or 
bronchiolitis is a disease of the airways <2 mm diameter (small bronchi and bronchioles), 
which is the major site of airflow obstruction in COPD. Small airways disease is one of the 
first pathologic abnormalities to occur. Increased inflammation is the predominant 
manifestation; the inflammatory cell changes in the small airways are similar to those in 
larger airways with increased CD8
+
 lymphocytes and CD8/CD4 ratio, leading to their 
narrowing and eventually obstruction.(Russi et al., 1999; MacNee, 2008)  
Contrary to chronic bronchitis and small airways disease, which generally involve distinct 
and well defined parts of the airways, the distribution of pulmonary emphysema 
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development in the lung is more variable. Pulmonary emphysema is defined as abnormal 
and permanent enlargement of airspaces distal to the terminal bronchioles accompanied by 
destruction of their wall and without obvious fibrosis.(Viegi et al., 2007) The major types 
of emphysema are distinguished based on the distribution of enlarged airspaces within the 
acinar unit, which is the lung parenchyma unit supplied by a single terminal bronchiole. 
Three major types of emphysema have been described: a) centriacinar or centrilobular 
emphysema, where the airspaces are distributed around the terminal bronchiole. This type 
of emphysema begins in the respiratory bronchioles and spreads peripherally, b) panacinar 
or panlobular emphysema, where the airspaces are distributed throughout the acinar unit 
uniformly and c) periacinar or paraseptal or distal acinar emphysema. It predominantly 
involves alveolar ducts and sacs, the distal portion of the acinus and the enlarged airspaces 
are found along the edge of the acinar unit, against a fixed structure. (Russi et al., 1999; 
MacNee, 2008) Bullous disease of the lung is an additional distinct form of emphysema, 
characterized by large and eventually growing bullae, which may compress adjacent 
relatively “healthy” lung. To further increase the variation of emphysema manifestation, 
combinations of these various forms of emphysema coexist in many patients.(Russi et al., 
1999) 
 Contrary to chronic bronchitis and small airways disease, which generally involve distinct 
and well defined parts of the airways, emphysema distribution in the lung is more variable 
and emphysema patterns may significantly differ between individuals. Emphysema is 
characterized as heterogeneous when distinct areas of destroyed parenchyma as well as 
relatively well-preserved lung tissue coexist.(Russi et al., 1999) When the areas of 
destroyed parenchyma are distributed throughout the lung and there are no lobes with 
obvious predominance of involvement, emphysema is characterized as homogeneous. To 
describe this variability, a simplified surgically oriented classification system based on CT 
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findings has been previously proposed, which considers the predominance of the involved 
lobes and distinguishes between: 1) homogeneous (with patchy areas or completely 
homogeneous), 2) moderately heterogeneous and 3) markedly heterogeneous (upper lobe, 
upper lobe and apical segment (lower lobe) or lower lobe) emphysema distribution.(Weder 
et al., 1997) Although this is not the only classification system proposed in literature, the 
general categorization of emphysema distribution in homogeneous and heterogeneous have 
been proven clinically useful, particularly for the selection of patients eligible for invasive 
treatments, such as lung volume reduction procedures.(S. J. Clark et al., 2014)  
B. Lung Hyperinflation: An Overview 
Definition, measurement and natural history of Lung Hyperinflation 
Lung hyperinflation is defined as an abnormal increase in the volume of air remaining in 
the lungs or in a region of a lung at the end of spontaneous expiration, that is in the end-
expiratory lung volume (EELV). The presence of lung hyperinflation is very frequent in 
COPD and is due to the combined effects of increased lung compliance, as a result of the 
permanently destructive changes of emphysema, and the development of expiratory flow 
limitation.(O’Donnell, 2006)  
Lung hyperinflation could be static, dynamic or both. Pulmonary static or resting 
hyperinflation refers to the permanent increase of EELV among COPD patients, compared 
to healthy subjects. It is mainly due to the destruction of pulmonary parenchyma and loss 
of elastic lung recoil and it is present during rest.(Tzani et al., 2011) Since inert gas 
dilution techniques may underestimate absolute lung volumes due to the presence of non-
communicating airways, body plethysmography remains the gold standard for the 
measurement of EELV and has been shown to be reliable. Another conventional measure 
of resting lung hyperinflation that has been used is the increase of total lung capacity 
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(TLC) more than 120% of predicted and/or the increase of other volume compartments 
(e.g. Residual volume (RV)) above the upper limits of normal. In practice, values 
exceeding these thresholds seem to be clinically important, however no consensus 
definition or a formal staging system for the severity of static hyperinflation currently 
exist.(O’Donnell & Laveneziana, 2006) 
In addition to or independently from static hyperinflation, dynamic hyperinflation (DH) of 
the lung may be observed at any stage of COPD. (O’Donnell, 2008; Tzani et al., 2011) DH 
refers to the variable and temporary increase in EELV above its baseline value, which 
occurs when in situations where expiratory flow limitation is suddenly worsened (i.e. 
during exacerbations) or when ventilatory demand is acutely increased, as it happens 
during exertion, anxiety, or transient hypoxaemia.(O’Donnell & Parker, 2006; Guenette, 
Chin, Cory, Webb, & O’Donnell, 2013; Thomas, Decramer, & O’Donnell, 2013) DH is 
usually measured by serial Inspiratory Capacity (IC) maneuvers which accurately reflect 
changes in EELV provided that TLC remains unaltered. The technique is described in 
detail later, in the methods section. EELV changes are distinct from changes in end-
inspiratory lung volume (EILV); the latter represents the combination of change in EELV 
and expansion of Tidal Volume (Vt) during exercise, and is not a measure of DH.(Guenette 
et al., 2013) 
Expiratory flow limitation and dynamic hyperinflation are clinical and pathologic concepts 
that have been identified more than 100 years ago; However, recent developments have 
revitalized the interest on these pathophysiological consequences of obstructive disease, 
with a provocative hypothesis recently proposing that the transition from peripheral 
airways disease to COPD follows the progress of severity of expiratory flow 
limitation.(Milic-Emili, 2004; Puente-Maestu & Stringer, 2006) The natural history of the 
development of lung hyperinflation in COPD patients remains unknown, because no 
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formal epidemiological studies exist; nevertheless, clinical experience indicates that 
hyperinflation develops slowly and insidiously over many years, similar to the decline in 
FEV1. It seems that closing volume and RV are the first volume components to increase, 
due to increased airway closure. EELV increases thereafter, reflecting the effects of 
worsening expiratory flow-limitation and alteration in static lung mechanics. Eventually, 
TLC increases along with lung compliance.(O’Donnell, 2006; O’Donnell & Laveneziana, 
2006) Although the negative effects of lung hyperinflation are not usually perceived by the 
patients until the disease is quite advanced, preliminary data indicate that EELV may be 
significantly increased even in patients with early stages of COPD.(O’Donnell & 
Laveneziana, 2006) This is why longitudinal studies in large COPD populations are 
required, in order to define the exact time course of volume changes in the various lung 
compartments during disease progression.  
Pathophysiology of dynamic hyperinflation 
In health, the relaxation volume of the respiratory system is dictated by the balance of 
forces between the inward elastic recoil pressure of the lung and the outward recoil 
pressure of chest wall. The equilibrium point is the lung volume where the net elastic recoil 
of the total respiratory system is zero. In healthy individuals the EELV during relaxed tidal 
breathing is approximately equal to the equilibrium point of the respiratory 
system.(O’Donnell & Laveneziana, 2006) 
In COPD, the elastic recoil of the lung is decreased due to the parenchymal desctruction, 
resulting to a higher relaxation volume compared to age-matched individuals; This 
condition is termed “static hyperinflation”. The EELV is also different compared to 
healthy individuals. Due to the expiratory flow limitation, the time needed for lung units to 
empty their volume and achieve their passive equilibrium point is significantly higher and 
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many of them do not reach their relaxation volume before a new inspiration is initiated. As 
a result, part of the gas that would have been expired, if alveolar units were not destroyed 
due to emphysema, remains “trapped” within the lung.  This is why EELV is increased 
compared to the expected relaxation volume, even during resting tidal breathing and the 
alveolar pressure at the end of the expiration is higher than the atmospheric pressure 
(intrinsic Positive End Expiratory Pressure (PEEP)).(Pride & Macklem, 1986; Younes, 
1991; O’Donnell & Laveneziana, 2006; Puente-Maestu & Stringer, 2006) The exact value 
of EELV in patients with COPD varies with the severity of expiratory flow-limitation, the 
effect of time-dependent parameters and the breathing pattern and is described by the 
following equation: 
EELV − Vr = Vt/e
Te/Trs 
-1 
where Vr = relaxation volume, Te = expiratory time, Trs =time constant for emptying of 
the respiratory system, Vt = tidal volume, and base e = 2.718282. (Vinegar, Sinnett, & 
Leith, 1979) This equation indicates that any increase in tidal volume, decrease in 
expiratory time or both could result to an elevation of EELV. 
During exercise minute ventilation must be increased in order to meet the elevated 
metabolic demands. This is achieved by increasing both the tidal volume and the 
respiratory rate (RR), which means that the expiratory time necessary to reach relaxation 
volume is reduced. In normal young subjects expiratory flow is fast enough to decrease 
end-expiratory lung volume.(Pride & Macklem, 1986; Henke, Sharratt, Pegelow, & 
Dempsey, 1988) In older subjects, EELV also decreases during moderate exercise, but 
tends to increase back to its resting levels in exercise of higher intensity.(Johnson, Reddan, 
Seow, & Dempsey, 1991) In COPD, as exercise is progressing more and more alveolar 
units are unable to empty their gas, because expiratory time decreases when the respiratory 
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rate increases, resulting in a typical rise in EELV. This acute increase in EELV above its 
baseline value is called DH and its degree is inversely related to the level of resting lung 
hyperinflation.(O’Donnell, Revill, & Webb, 2001; Puente-Maestu et al., 2005; Puente-
Maestu & Stringer, 2006) 
Pathophysiological and clinical consequences of DH 
The acute increase of lung hyperinflation, such as during exercise, is accompanied by 
several negative consequences, due to the altered respiratory mechanics.(O’Donnell & 
Laveneziana, 2006) DH results in sudden increases in the elastic loads on the inspiratory 
muscles as tidal volume is forced to operate at the upper extreme of the respiratory 
system’s pressure-volume relation, thus increasing the work and oxygen cost of 
breathing.(O’Donnell, Bertley, Chau, & Webb, 1997) Due to the maximal shortening of 
the diaphragm muscle fibers and the increased mechanical loading, DH can predispose 
inspiratory muscles to fatigue.(Sinderby et al., 2001) Moreover, DH poses a mechanical 
“barrier” for tidal volume to appropriately increase during exercise, resulting in ventilatory 
exercise limitation. In patients with severe ventilation-perfusion abnormalities this inability 
to further increase tidal volume can result to arterial desaturation and retention of carbon 
dioxide during exercise.(O’Donnell, D’Arsigny, Fitzpatrick, & Webb, 2002)  
Furthermore, DH negatively affects cardiac function in various ways.(Puente-Maestu & 
Stringer, 2006) Right ventricular preload is usually reduced due to decreased venous 
return.(Miller, Pegelow, Jacques, & Dempsey, 2005) Alternatively, right ventricular 
afterload could  be increased due to high pulmonary vascular resistance associated with 
breathing in lung volumes close to TLC.(Oswald-Mammosser et al., 1998; Ranieri, 
Dambrosio, & Brienza, 1996) Finally, left ventricular afterload might be increased, since 
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large swings of intrathoracic pressure during exercise may result to left cardiac 
dysfunction.(Montes de Oca, Rassulo, & Celli, 1996) 
Several clinical manifestations of DH have been previously reported in literature, with 
exercise limitation being one of the most characteristic. COPD patients establish a poor 
exercise performance, either during submaximal exercise, where they present with reduced 
endurance or during maximum exercise, where they establish marked reductions in peak 
oxygen consumption.(Gallagher, 1994; Puente-Maestu & Stringer, 2006; Tzani et al., 
2011). Moreover, DH has been previously associated with increased dyspnea, mainly 
during exercise and exacerbations. In these conditions the respiratory drive is acutely 
increased but the ability of ventilation to match the increased needs is greatly hampered, so 
dyspnea becomes intolerable very quickly for most COPD patients;(Thomas et al., 2013) 
these exercise abnormalities could be further accompanied by exertional desaturation 
and/or hypercapnia, as already been discussed. Furthermore, DH might have a prognostic 
impact in COPD. Literature data indicate a potential correlation between lung 
hyperinflation, COPD exacerbations (Zaman, Mahmood, & Altayeh, 2010) and annual 
decline of FEV1 among COPD patients,(Yuan et al., 2009) while resting hyperinflation has 
been previously reported as an independent predictor of respiratory and all-cause mortality 
in COPD.(Casanova et al., 2005) 
  
C. Study hypothesis 
As already discussed, DH is the result of increased lung compliance and expiratory flow 
limitation, which are both developed because of the disarrangement of the lung structure. 
The outer attachments of small bronchi and bronchioles to the adjacent alveolar walls 
maintain the tubular integrity of the airways. Loss of these attachments due to emphysema 
results to distortion and irregularities of the airways because of the loss of lung elastic 
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recoil, which may also lead to airflow limitation.(MacNee, 2008) So the question which 
arises is whether the distribution of these abnormalities (irregular, such as in heterogeneous 
emphysema or more uniform, such as in homogeneous emphysema) is associated with the 
severity of DH and the establishment of its consequences among COPD patients.  
Primary study hypothesis 
Null Primary Hypothesis (H0): There is no difference in dynamic hyperinflation between 
COPD patients with homogeneous compared to matched COPD patients with 
heterogeneous emphysema 
Alternative Primary Hypothesis (H1): Dynamic hyperinflation differs significantly between 
COPD patients with homogeneous and matched COPD patients with heterogeneous 
emphysema. 
Secondary Study Hypothesis 
Null Secondary Hypothesis: There is no difference in maximal exercise parameters 
between COPD patients with homogeneous and matched COPD patients with 
heterogeneous emphysema 
Alternative Secondary Hypothesis: There are statistically significant differences in one or 
more maximal exercise parameters between COPD patients with homogeneous and 
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II. LITERATURE REVIEW 
Currently, most of the published literature regarding the impact of emphysema distribution 
on clinical outcomes in COPD is related to lung volume reduction (LVR) procedures, 
either surgical or bronchoscopic. When the criterion of heterogeneity and particularly 
upper lobe disease is fulfilled, patients present with improved exercise capacity,(Wan et 
al., 2006) functional improvement in terms of FEV1,(Wisser et al., 1998) better health 
related quality of life,(Wood et al., 2007) and improved survival (Fishman et al., 2003), 
after the procedure. However, rest of data regarding the association between a patient’s 
clinical phenotype and emphysema distribution are scarce and, to the author’s knowledge, 
no study has yet evaluated its impact on DH during maximal exercise.   
One of the first studies on the field that assessed the effect of emphysema distribution on 
functional and clinical characteristics was conducted by Parr, Stoel, Stock & Stockley 
(2004). The authors studied 102 patients, 65 of whom had predominantly basal and the rest 
had predominately apical emphysema. The two groups were matched for emphysema 
volume and age and authors utilized matched pair analysis in order to identify potential 
differences in functional parameters, according to emphysema distribution. Basal 
emphysema distribution was associated with a greater impairment of FEV1, but less 
impairment of gas transfer (as measured by diffusion coefficient for carbon monoxide 
(KCO)), compared to apical distribution.(Parr et al., 2004). 
This study indicated that emphysema distribution may have an impact on lung physiologic 
parameters; however, it carried several limitations. The most important is that it was 
conducted in patients with severe alpha1 deficiency. Although these patients present with 
emphysema, its pathogenetic mechanism and pathology is quite different from the one of 
COPD. Moreover, in alpha1 deficiency emphysema usually predominates in lower lobes, 
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while in COPD it usually predominates in upper lobes,(Russi et al., 1999) when it is 
heterogeneous. Finally, authors did not investigate at all the potential impact of 
emphysema distribution on DH and other exercise variables. 
Another study of alpha1 deficiency patients, which was conducted later confirmed this 
association between emphysema distribution and pulmonary function parameters. Fifteen 
patients with normal FEV1 and KCO were compared to three groups of patients with 
various combinations of FEV1 and/or KCO abnormalities. Again, the authors concluded 
that lower zone emphysema is associated with worse FEV1 values and better KCO values, 
compared to upper zone emphysema.(Holme & Stockley, 2007) Likewise, this was a study 
conducted in a non-COPD population, while any potential associations with DH or other 
exercise parameters were not studied. 
One of the most important studies in the field, in terms of various types of emphysema 
distribution tested, was the one of Mair et al (2009). One hundred twenty nine COPD 
patients with smoking-related disease underwent CT assessment of the extent and 
distribution of their emphysema and were categorized as upper/lower zone and core/rind 
predominant. Core predominance was associated with more impaired resting pulmonary 
function, worse dyspnea and higher BODE (B: Body Mass Index, O:Obstruction, D: 
Dyspnea and E: exercise capacity) index, while upper predominance was associated with 
higher scores in St George Respiratory Questionnaire. The authors concluded that the 
core/rind categorization of emphysema distribution correlates well with clinical features 
among COPD patients.(Mair et al., 2009) Although this is a study conducted in a relatively 
big cohort of COPD patients it carries two limitations: core predominance could be present 
either in patients with homogeneous or in patients with heterogeneous emphysema, so 
which of these two emphysema distribution entities correlates best with clinical parameters 
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cannot be distinguished. The second limitation is that, like in previous studies in the field, 
the impact of emphysema distribution on DH was not investigated.  
Contrary to the previous studies, de Torres et al (2011) failed to establish any associations 
between clinical parameters and emphysema distribution. A cohort of 115 COPD patients 
with mild to moderate disease was evaluated and potential correlations with clinical 
parameters (resting pulmonary function testing parameters (PFTs), severity of dyspnea, 6 
minute walking test (6MWT), exacerbation rate, BODE index and St. George Respiratory 
Questionnaire) were investigated for four different emphysema distributions: core/peel and 
upper/lower predominance.(de Torres et al., 2011) Once again the impact of emphysema 
distribution on DH was not investigated. 
In conclusion, data on published literature regarding potential correlations between 
emphysema distribution and physiologic and clinical parameters in COPD patients are 
scarce. Although there is some evidence that the site of parenchymal destruction is 
associated with resting pulmonary function variables, severity of dyspnea, 6MWT distance 
and quality of life in patients with alpha1 deficiency and in COPD patients with moderate 
to severe disease, no study has yet evaluated emphysema distribution’s impact on DH and 
maximum exercise testing parameters. Furthermore, the published studies have adopted 
various techniques to characterize emphysema distribution, while some of them were 
conducted in non-COPD patients with emphysema, so results are not easy to compare.  
Against his background we conducted a retrospective nested case-control study in order to 
identify:  
a) the differences in the degree of DH occurring during maximum cardiopulmonary 
exercise testing (CPET) between COPD patients with heterogeneous and matched 
COPD patients with homogeneous emphysema, 
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b)  the differences in maximal CPET parameters between COPD patients with 
heterogeneous and matched COPD patients with homogeneous emphysema and 
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III. MATERIAL AND METHODS 
A. Study population 
Prospectively collected data on COPD outpatients who were assessed at the Respiratory 
Biomedical Research Unit of Royal Brompton Hospital between June 2009, and August, 
2013 for potential eligibility to undergo a bronchoscopic LVR procedure, were 
retrospectively analyzed. Data on full lung function measurements, thoracic high resolution 
computed tomography (HRCT) and breath by breath data from maximum cycling CPET 
with inspiratory maneuvers were extracted from the hospital’s records. The COPD patients 
were in stable clinical condition and were under treatment with various combinations of β2-
agonists, anticholinergic drugs and inhaled corticosteroids, according to guidelines. All 
patients gave their informed consent for their initial participation in the studies.(Shah et al., 
2013; S. J. Clark et al., 2014; Davey et al., 2014) Corresponding identification numbers for 
all clinical trials are included in the Appendix.   
 
B. Study measurements 
Pulmonary Function Testing 
Spirometry, gas transfer and lung volumes measurement by body plythesmography were 
conducted using a Compact Lab System (Jaeger, Hoechberg, Germany). FEV1, FVC, 
FEV1/FVC ratio, TLC, Functional Residual Capacity (FRC), RV, RV/TLC ratio, Carbon 
Monoxide Diffusion Capacity (TLCO) and KCO were recorded for each patient. 
Arterialized capillary blood samples were used to measure arterial PaO2 and arterial 
PaCO2. Arterialized capillary blood sampling is carried out routinely by clinical 
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physiologists in Royal Brompton Hospital and is better tolerated than an arterial puncture, 
while giving equivalent results.(Zavorsky, Cao, Mayo, Gabbay, & Murias, 2007)  
The European Coal and Steel Community predicted values were used for lung function 
measurements (Quanjer et al., 1993) and the values of carbon monoxide diffusion capacity 
and transfer coefficient were adjusted for haemoglobin concentration (TLCOc and KCOc 
correspondingly).(E. H. Clark, Woods, & Hughes, 1978) All PFT values which were used, 
were measured prior to any bronchoscopic intervention and within a 6-month interval from 
both the HRCT and the maximum CPET.  
HRCT acquisition and interpretation 
Imaging was performed for clinical indications on 4-slice multidetector CT (Volume 
Zoom, Siemens, Erlangen, Germany), or 64-slice CT (Somatom Sensation 64, Siemens, 
Erlangen, Germany).  Images were either acquired at 10-mm intervals (4-slice CT) or 
using a volumetric acquisition (64-slice CT) in a supine position from the lung apices to 
the bases at full inspiration without the use of intravenous contrast. Images were 
reconstructed at thin section width (1.0mm to 1.5mm) using a high spatial resolution 
algorithm and reviewed on a workstation at appropriate window settings for viewing the 
lung parenchyma (window centre = −500HU; window width = 1500HU). 
Images were transferred to a post-processing workstation (Leonardo, Siemens) and 
quantitative lung density analysis was performed using the Pulmo CT program (Siemens, 
Version No.), which automatically segments the lung and calculates pixel attenuation 
coefficients as previously described (Gierada et al., 2001) with a minimum segmentation 
threshold of -1024HU. (Figure 1) Three representative slices of the lungs were analysed: 
(a) at the level where the top of the aortic arch just appears; (b) at the level of the carina, 
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where clear separation of the right and left main bronchi just becomes visible; and (c) at 
the level where neither diaphragm and nor abdominal viscera are visible (Figure 1).  
 
Figure 1. A) Upper slice (at the level where the top of the aortic arch just appears), B) 
Middle slice (at the level of the carina, where clear separation of the right and left main 
bronchi just becomes visible) and C) Lower slice (at the level where neither diaphragm 
and nor abdominal viscera are visible) 
At each level, the program provides a total emphysema index, that is, the percentage of 
whole lung with attenuation values below a threshold of -900 HU, as well as a severe 
emphysema index, defined as percentage of whole lung with attenuation values below a 
threshold of -950 HU.(Gevenois, de Maertelaer, De Vuyst, Zanen, & Yernault, 1995; 
Gietema et al., 2011; Wang et al., 2013) An alternative threshold for emphysema definition 
of -960 HU has also previously been reported and we included this threshold as an 
additional quantitative parameter (Gierada et al., 1997) (Figure 2). 
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Figure 2. A) Upper slice transferred to the post-processing workstation, where 
quantitative lung density analysis was performed using the Pulmo CT program. B) 
Histogram of distribution of lung attenuation values, measured in HU in the upper slice for 
several potential emphysema thresholds. 
 
To enable us to classify subjects as having either homogeneous or heterogeneous 
emphysema, we defined heterogeneous emphysema as a difference of >25% between the 
highest and lowest quantitative emphysema scores obtained, based on previous precedents 
of visual analysis.(National Emphysema Treatment Trial Research Group, 2001) 
Maximum CPET 
All patients performed an incremental symptom-limited CPET on a cycle ergometer 
(Jaeger Ergoline 800), under continuous monitoring of pulse oximetry (SaO2), heart rate 
(HR), and a 12-lead electrocardiogram. The test consisted of 3 minutes of rest, 3 minutes 
of unloaded pedaling at 50-60 rpm, and then a ramp protocol with work rate (WR) 
increasing either 5 or 10 watts/minute, followed by 2 minutes of recovery.(American 
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Thoracic Society & American College of Chest Physicians, 2003) Severity of dyspnea was 
assessed using the 12 point modified Borg dyspnea scale, which is a linear, Likert type 
scale (see Appendix) that evaluates the subjective feeling of exertional dyspnea. Borg scale 
was originally a 21 point category scale for measuring perceived exertion during 
exercise,(Borg, 1982) but it was later modified to a 12 point scale and was adapted to 
estimate breathlessness.(Burdon, Juniper, Killian, Hargreave, & Campbell, 1982) 
Gas exchange values and exercise parameters were collected breath-by-breath, using a 
Jaeger Oxycon system,(Beaver, Wasserman, & Whipp, 1986; Wasserman, 2005) allowing 
measurement of: respiratory rate (RR), Vt, oxygen uptake (VO2), carbon dioxide 
production (VCO2), end-tidal oxygen (PETO2) and end-tidal carbon dioxide (PETCO2). 
The anaerobic threshold (AT), oxygen pulse (VO2/HR), respiratory exchange ratio (RER), 
minute ventilation (VE) and the ventilator equivalent for carbon dioxide at peak VO2 
(VE/VCO2@VO2 peak) were also calculated, as previously described.(Wasserman, 2005)  
Inspiratory maneuvers 
Each patient performed a total of four inspiratory maneuvers at 0, 1, 2, and 3 minutes of 
rest, in order IC to be measured, as previously described (Guenette et al., 2013) and resting 
IC (rIC) was calculated by averaging these values. To increase accuracy, a minimum of 4 
stable breaths were conducted prior each inspiratory maneuver and volume was 
continuously monitored. This way the absolute volume of each IC could be accounted for 
any potential alterations of the EELV.(Guenette et al., 2013) Peak IC (pIC) was calculated 
by another inspiratory maneuver which was conducted during the last 30 seconds of peak 
exercise (Figure 3). This technique was selected to assess hyperinflation and changes in 
EELV during exercise, as previous data indicate its high reliability and reproducibility 
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during rest and incremental cycling exercise in COPD patients.(Yan, Kaminski, & 
Sliwinski, 1997; O’Donnell et al., 2009) 
The change of IC from rest to peak exercise (ΔIC) was utilized as a measure of DH and 
was calculated as rIC-pIC. For every patient, ΔIC was expressed as a % percentage of rIC, 
that is: ΔIC%=(ΔIC/rIC) X100%. All exercise tests were performed before any 
bronchoscopic intervention took place and without oxygen supplementation. 
 
Figure 3. Measurement of IC during an inspiratory maneuver. B1, B2, B3, B4,….correspond 
to number of breaths during tidal breathing and before the conduction of the IC maneuver 
Statistical analysis 
Statistical analysis was conducted utilizing the PASW (Predictive Analytics Software by 
SPSS Inc®) version 19 for Windows 2008. Distribution of values was assessed using the 
Shapiro-Wilk test of normality; continuous variables are described as mean±1 standard 
deviation or as median (minimum-maximum), accordingly. Group comparisons in PFTs, 
DH and exercise parameters were conducted utilizing either the independent samples 
Student’s t-test or the Mann-Whitney test, depending on the normality of their distribution. 
Pearson r or Spearman rho were used to describe parametric and non-parametric 
correlations between emphysema distribution indices, DH measures, and exercise 
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parameters. Scatterplots were utilized to graphically describe the correlations between 
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A total of 136 COPD patients of various severity were assessed for potential eligibility to 
undergo a bronchoscopic or surgical LVR procedure between April 2002 and August 2013. 
From this initial population, 38 patients were excluded, because they had undergone a 
thorax CT scan which could not be used for further analysis (images were neither acquired 
at 10-mm intervals nor using a volumetric acquisition). From the remaining 98 patients, 
another 34 were excluded for any of the following reasons: a) they had undergone an 
endurance and not an incremental CPET, b) they had undergone an incremental CPET, but 
it was submaximal and c) exercise data could not be fully retrieved due to an older 
software version used. The remaining 64 COPD patients, who fulfilled the enrolment 
criteria and constituted the final study population, had been all assessed at the Respiratory 
Biomedical Research Unit of Royal Brompton Hospital between June 2009, and August, 
2013. (Figure 4) 
 
Figure 4. Study flowchart 
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The baseline characteristics of the final study population are presented in Table 2. When 
the -950 HU emphysema threshold was applied, 50 patients (78.1%) presented with 
heterogeneous and 14 patients (21.9%) with homogeneous emphysema (group Het and 
group Hom correspondingly). 
Table 2. Demographic characteristics for the whole study population 












FEV1 %predicted 31.5±11.2 
FEV1/FVC 28.6±6.9 
TLC %predicted 136.8±15.3 
RV %predicted 230.3±42.4 
RV/TLC (%) 61.4±7.9 
FRC %predicted 185.6±35.9 
TLCOc %predicted 34±10 
KCOc %predicted 45.1±12 
PaO2 (kPa) 9.6±1.2 
PaCO2 (kPa) 4.8±0.8 
BMI: Body Mass Index; FEV1: Forced Expiratory Volume in 1 second; FVC: Forced Vital 
Capacity; TLC: Total Lung Capacity; RV: Residual Volume; FRC: Functional Residual 
Capacity; TLCOc: Carbon Dioxide Diffusion Capacity; KCO: Carbon Dioxide Diffusion 
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Coefficient; PaO2: arterial Oxygen Partial Pressure; PaCO2: arterial Carbon Dioxide Partial 
Pressure 
 
 An initial attempt for patients in Hom group to match the same number of patients in Het 
group (1:1 matching) for age, FEV1 and TLCOc was made. However, the two patient 
groups (Hom and Het) were found to be matched not only regarding these three selected 
variables, but also regarding gender, body mass index (BMI), resting PFTs and gas transfer 
parameters, which resulted to an approximate 1:3 matching. The number of patients in the 
two groups (Hom and Het) was identical when the alternative -960 HU emphysema 
threshold was applied. The baseline demographic characteristics of the two groups are 
presented in Table 3. 
Table 3. Baseline characteristics of the two study groups 



















) 24±4.5 25.6±3.6 0.243 
FEV1 %predicted 32.4±11.4 28.1±10.3 0.213 
FEV1/FVC 29.1±7 26.5±6.4 0.216 
TLC %predicted 137±16.4 132.4±9.4 0.198 
RV %predicted 232.8±44.6 220.7±32 0.365 
RV/TLC (%) 61.6±8.5 60.8±5.2 0.757 
FRC %predicted 189.9±31.5 168.8±47.4 0.059 
TLCOc %predicted 34.1±10 33.3±11.5 0.867 
KCOc %predicted 45.8±12 40±12.1 0.300 
PaO2 (kPa) 9.6±1.3 9.2±1 0.527 
PaCO2 (kPa) 4.8±0.7 5.1±1.5 0.398 
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BMI: Body Mass Index; FEV1: Forced Expiratory Volume in 1 second; FVC: Forced Vital 
Capacity; TLC: Total Lung Capacity; RV: Residual Volume; FRC: Functional Residual 
Capacity; TLCOc: Carbon Dioxide Diffusion Capacity; KCOc: Carbon Dioxide Diffusion 
Coefficient; PaO
2




Exercise parameters for the whole population are presented in Table 4, while group 
comparisons are presented in Table 5. Although both dyspnea and muscle endurance were 
evaluated during exercise, all patients stopped because of dyspnea and the degree of 
breathlessness did not differ between groups. Only 15 patients (11 from Het group and 4 
from Hom group) reached AT during maximal CPET, thus corresponding exercise 
variables (AT %predicted, Ventilatory Equivalent for carbon dioxide at AT 
(VE/VCO2@AT), End Tidal Carbon Dioxide at AT (PETCO2@AT) and Oxygen Pulse at 
AT (VO2/HR@AT)) were not further analyzed. No patient presented with any symptom or 
sign such as dizziness, chest pain suggestive of ischemia or severe arrhythmias, indicating 
that exercise testing should be terminated before symptom limitation, according to 
guidelines.(American Thoracic Society & American College of Chest Physicians, 2003) 
Patients in the Hom group displayed more DH during exercise, as ΔIC% was significantly 
higher among Hom group compared to Het group; 39.8% vs 31.2% (p=0.031). No other 
differences were noted between the groups regarding CPET parameters. No other 
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Table 4. Exercise parameters for the whole study population 
Exercise parameter Study population 
(N=64) 
rIC (lit) 2.2±0.7 
pIC (lit) 1.5±0.5 




Peak VE (lit) 34(15-84) 
Peak Vt (lit) 1.1(0.53-2.33) 
Peak VO2 (ml/kg/min) 13.1(7.8-26.2) 
Peak VO2 %predicted 50.4±15.5 
Peak WR %predicted 26(5-73) 
Peak VCO2 (ml) 820.9(361.7-2023.4) 
RER 0.9(0.4-1.5) 
Peak HR %predicted 75.9±13.7 
Peak PETO2 (kPa) 15±1.1 
Peak PETCO2 (kPa) 4.6(2.3-8.3) 
Peak VE/VCO2 39.6(21-72.2) 
Peak VO2/HR %predicted 67.2±20 
RR (breaths/min) 31.5(18-56) 
rSPO2 (%) 95(88-99) 
pSPO2 (%) 89(79-98) 
ΔSPO2  6±3.3 
rIC: rest Inspiratory Capacity; pIC: peak Inspiratory Capacity; rBorg: rest Borg scale score; 
pBorg: peak Borg scale score; VE: Minute ventilation; Vt: Tidal Volume; VO2: Oxygen 
Consumption; WR: Work Rate; VCO2: Carbon Dioxide Production; RER: Respiratory 
Exchange Ratio; HR: Heart Rate; PETO2: End Expiratory Oxygen partial pressure; 
PETCO2: End Expiratory Carbon Dioxide partial pressure; VE/VCO2: Ventilatory 
Equivalent for Carbon Dioxide; VO2/HR: Oxygen Pulse; rSPO2: rest arterial Oxygen 
Saturation; pSPO2: peak arterial Oxygen Saturation  
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Table 5. Comparison of exercise parameters between patients with heterogeneous and 
homogeneous emphysema 





rIC (lit) 2.2±0.7 2.2±0.5 0.932 
pIC (lit) 1.5±0.5 1.3±0.3 0.240 
ΔIC % 31.2±13 39.8±9.8 0.031 
rBorg 1(0-5) 2(0-2) 0.441 
pBorg 7(4-10) 7(5-7) 0.807 
ΔBorg 5(1-9) 5(3-7) 0.852 
Peak VE (lit) 34(15-47) 32(18-84) 0.593 
Peak Vt (lit) 1.1(0.5-2.3) 1(0.7-1.4) 0.739 
Peak VO2 (ml/kg/min) 13.3(7.9-26.2) 12.5(7.8-26) 0.349 
Peak VO2 %predicted 49(13-99) 44(14-67) 0.246 
Peak WR %predicted 26(5-73) 34(12-59) 0.361 
Peak VCO2 (ml) 780.6(404-2023.4) 934.6(361-1025) 0.944 
RER 0.9(0.4-1.3)  0.9(0.4-1.5) 0.662 
Peak HR %predicted 75.5(42-106) 75.5(65-86) 0.802 
Peak PETO2 (kPa) 14.9(13-18) 14.9(11.4-16) 0.441 
Peak PETCO2 (kPa) 4.7(2.3-6.7) 4.6(3.6-8.3) 0.687 
Peak VE/VCO2 39.4(26.9-72.2) 41.6(21-48.3) 0.834 
Peak VO2/HR %predicted 66.6(14.4-112.3) 59(20.4-82) 0.131 
RR (breaths/min) 32.9±8.9 31.2±9.4 0.545 
rSPO2 (%) 94.5(88-99) 96(91-98) 0.323 
pSPO2 (%) 89(79-98) 89(80-95) 0.869 
ΔSPO2  6(0-12) 6.5(3-11) 0.674 
rIC: rest Inspiratory Capacity; pIC: peak Inspiratory Capacity; rBorg: rest Borg scale score; 
pBorg: peak Borg scale score; VE: Minute ventilation; Vt: Tidal Volume; VO2: Oxygen 
Consumption; WR: Work Rate; VCO2: Carbon Dioxide Production; RER: Respiratory 
Exchange Ratio; HR: Heart Rate; PETO2: End Expiratory Oxygen partial pressure; 
PETCO2: End Expiratory Carbon Dioxide partial pressure; VE/VCO2: Ventilatory 
Equivalent for Carbon Dioxide; VO2/HR: Oxygen Pulse; rSPO2: rest arterial Oxygen 
Saturation; pSPO2: peak arterial Oxygen Saturation  
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Figure 5. Differences between groups in rIC, pIC and absolute ΔIC. 
Emphysema distribution as a continuous variable  
Alternatively, emphysema was treated as a continuous variable and specifically as a ratio 
of average emphysema score of the upper and middle slice versus average emphysema 
score of the lower slice (UM/L) for both 950 and 960 emphysema thresholds. A high ratio 
therefore represents heterogeneous emphysema with upper lobe predominance.  
Table 5 presents the non-parametric correlations between UM/L ratio, ΔIC% and CPET 
parameters. The UM/L ratio established a weak, inverse but significant correlation to 
ΔIC% for both -950 and -960 emphysema thresholds (Spearman rho=-0.264, p=0.049; 
Spearman rho=-0.246, p=0.049, correspondingly). Moreover, peak VO2 %predicted, peak 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 05:53:34 EET - 137.108.70.7
52 
 
VO2/HR %predicted and peak RR were all positively correlated to UM/L ratio. (Table 6 
and Figures 6-13) 
Table 6. Correlations between emphysema distribution and exercise parameters, for both 
emphysema thresholds 
Exercise parameter 950UM/L 960UM/L 
ΔIC % -0.264* -0.246* 
rBorg -0.018 0.016 
pBorg 0.096 0.068 
ΔBorg 0.078 0.030 
Peak VE (lit) 0.186 0.040 
Peak Vt (lit) 0.025 0.053 
Peak VO2 (ml/kg/min) 0.050 0.033 
Peak VO2 %predicted 0.340** 0.341** 
Peak WR %predicted 0.087 0.040 
Peak VCO2 (ml) 0.130 0.128 
RER 0.075 0.110 
Peak HR %predicted -0.074 -0.086 
Peak PETO2 (kPa) 0.193 0.197 
Peak PETCO2 (kPa) -0.097 -0.109 
Peak VE/VCO2 -0.006 0.010 
Peak VO2/HR %predicted 0.398** 0.390** 
Peak RR (breaths/min) 0.300* 0.266* 
rSPO2 (%) 0.046 0.030 
pSPO2 (%) 0.079 0.069 
ΔSPO2  -0.099 -0.091 
IC: Inspiratory Capacity; rBorg: rest Borg scale score; pBorg: peak Borg scale score; VE: 
Minute ventilation; Vt: Tidal Volume; VO2: Oxygen Consumption; WR: Work Rate; VCO2: 
Carbon Dioxide Production; RER: Respiratory Exchange Ratio; HR: Heart Rate; PETO2: 
End Expiratory Oxygen partial pressure; PETCO2: End Expiratory Carbon Dioxide partial 
pressure; VE/VCO2: Ventilatory Equivalent for Carbon Dioxide; VO2/HR: Oxygen Pulse; 
rSPO2: rest arterial Oxygen Saturation; pSPO2: peak arterial Oxygen Saturation  
* Significant correlation at 0.05 level; **Significant correlation at 0.01 level 
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Figure 6. Correlation between 950UM/L ratio and ΔIC % 
 
 
Figure 7. Correlation between 950UM/L ratio and Peak VO2 %predicted 
rho=-0.264, p=0.035 
rho=0.340, p=0.011 
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Figure 8. Correlation between 950UM/L ratio and Peak VO2/HR %predicted 
 
Figure 9. Correlation between 950UM/L ratio and Peak RR 
rho=0.369, p=0.006 
rho=0.300, p=0.017 
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Figure 10. Correlation between 960UM/L ratio and ΔIC %percentage of rIC 
 
Figure 11. Correlation between 960UM/L and Peak VO2 %predicted 
rho=-0.246, p=0.049 
rho=0.341, p=0.011 
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Figure 12. Correlation between 960UM/L ratio and Peak VO2/HR %predicted 
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This retrospective nested case-control study aimed to investigate whether emphysema 
distribution has any impact on DH and exercise parameters during a maximum CPET, for 
the first time in literature. Patients with homogeneous emphysema tended to hyperinflate 
more compared to the ones with heterogeneous emphysema, although no differences were 
noted regarding exercise variables, between the groups. Furthermore, emphysema 
heterogeneity and particularly upper lobe predominance correlated inversely with DH, and 
positively with peak oxygen consumption, peak oxygen pulse and peak RR.  
Emphysema distribution varies significantly among individuals and possibly represents the 
different pathogenetic patterns of the disease development.(Mair et al., 2009) Three 
different subtypes of emphysema have been recognized: a) centriacinar emphysema, which 
predominantly involves the upper lobes and is associated with long-standing cigarette 
smoking, b) panacinar emphysema, which mainly involves the lower lobes and is 
frequently found in patients with a1-deficiency and c) distal acinar emphysema, which 
tends to occur adjacent to the pleura or the fibrous septa.(Russi et al., 1999) These 
pathologic lesions are found in various combinations in each patient, comprising a 
heterogeneous or homogeneous emphysema pattern, as classified by CT imaging.(Weder et 
al., 1997; Russi et al., 1999) Mair et al (2009) indicated that emphysema distribution is 
associated with several clinical features, such as FEV1, BMI, BODE index and Saint 
George Respiratory Questionnaire score; however, these associations were most evident 
among patients with core versus rind predominant, rather than upper versus lower 
predominant emphysema. Moreover, the presence of heterogeneity has been repeatedly 
associated with improved outcomes and increased survival after a LVR 
procedure.(McKenna et al., 1997; Sanchez, Kucharczuk, Su, Kaiser, & Cooper, 2010) 
Although the theoretical background of these interventions is the restoration of lung elastic 
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recoil and the improvement of lung mechanics, the impact of emphysema distribution on 
DH has never been previously assessed.  
Both pathologic hallmarks of COPD, airway inflammation and parenchymal destruction, 
contribute to the development of DH.(Puente-Maestu & Stringer, 2006) During exercise, 
the increased airway resistance and the decreased elastic recoil pressure, result in increased 
time constants for alveolar units, so as the RR and expiratory flow increase, the expiratory 
time available for exhalation becomes insufficient.(O’Donnell & Laveneziana, 2006; 
Gagnon et al., 2014) Given the variety of distribution of parenchymal destruction among 
COPD patients, it is possible that its general pattern might have an impact on lung 
deflation. In our study, patients with heterogeneous emphysema, that is with unequally 
distributed parenchymal damage, presented with significantly less DH during maximal 
exercise, compared to the ones with homogeneous one. In patients with heterogeneous 
emphysema, lung areas with distinct destruction coexist with areas where lung parenchyma 
is well preserved.(Russi et al., 1999) The presence of areas with severe emphysematous 
destruction could be accompanied with the compression of adjacent lung tissue, a 
phenomenon less evident among patients with homogeneous emphysema. One could 
hypothesize that this compression poses a mechanical barrier for the further increase of end 
expiratory lung volume, resulting to less DH during maximal exercise, but this is a 
hypothesis that needs to be further investigated.  
Interestingly, no CPET parameter differed significantly between patients of Het and Hom 
group. It is well established that medical or other interventions targeting on lung 
hyperinflation improve exercise tolerance among COPD patients.(O’Donnell, Lam, & 
Webb, 1998; Maltais et al., 2005; Hopkinson et al., 2005) Tzani et al (2011) reported that 
DH was associated with increased exertional dyspnea and reduced maximum exercise 
capacity in a cohort of COPD patients; however a relatively high value of end expiratory 
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lung volume (≥75% TLC) was used as a threshold for group categorization. In another 
study ΔIC was associated with exercise desaturation; nevertheless, this study utilized a 
submaximal exercise testing and not maximal CPET.(Zafar, Tsuang, Lach, Eschenbacher, 
& Panos, 2013)  The relatively small size of Hom group, and the significant, but rather 
small (approximately 8.5%) difference in ΔIC% between the groups, might justify our 
results. Nevertheless, apart from these potential limitations, our study has compared the 
exercise capacity in two COPD groups which differed in the distribution of parenchymal 
involvement, so exercise performance might be affected, apart from DH, by other potential 
pathological or mechanical factors which could be distinct in these two populations and 
remain to be identified. 
When emphysema distribution was treated as a continuous variable, significant 
correlations were established with several CPET parameters. The higher the emphysema 
heterogeneity with upper lobe predominance, as manifested by increased UM/L ratio, the 
lower the ΔIC%, and the higher the peak O2 consumption and the peak oxygen pulse. Lung 
hyperinflation is the most probable cause of this circulatory impairment during exercise, as 
it has been previously established.(Miller et al., 2005; Vassaux et al., 2008; Tzani et al., 
2011) The use of respiratory muscles during active expiration in combination with DH 
which produces an intrinsic PEEP could reduce venous return and right ventricular 
preload.(Puente-Maestu & Stringer, 2006) Left ventricular afterload may also increase 
during exercise in COPD patients, since high intrathoracic pressure swings have to be 
generated to overcome the increased high elastic and resistive loads.(Montes de Oca et al., 
1996; Gagnon et al., 2014) These combined effects of DH result to functional hypovolemia 
during exercise,(Vassaux et al., 2008) which may have an impact on stroke volume, as 
manifested in our study by its inverse association to oxygen pulse. Whether the unequal 
distribution of parenchymal destruction itself, as seen in heterogeneous emphysema, 
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compromise cardiac function less, compared to the homogeneous one, due to the potential 
compensatory effect of preserved lung areas and irrespectively from the degree of DH, is a 
hypothesis that remains to be tested. Another interesting finding regarding CPET 
parameters in this study is that peak RR is positively associated to emphysema 
heterogeneity, which indicates the development of a rapid swallow breathing pattern 
during exercise, among these COPD patients, possibly due to the presence of 
“compressed” lung. 
Methodological issues 
Although data were retrospectively analyzed, their prospective collection has minimized 
the general bias seen in this kind of studies. COPD patients who were included in the study 
were followed-up in a tertiary hospital and they were assessed for a LVR procedure, so 
results should be generalized in primary care COPD populations with some caution. This 
may also explain the high proportion of heterogeneous emphysema identified. The study is 
strengthened by the single center approach, which has minimized bias that could occur in 
multicenter cohorts, regarding different patient populations included and various 
measurement techniques applied. The nested case-control design allowed matching for 
other parameters which could potentially affect DH, such as resting lung function. 
Although the categorization of emphysema distribution was performed with the utilization 
of a well-established technique, the use of UM/L ratio as a continuous variable to describe 
upper-lobe predominance in sub analysis has not been reported previously and needs to be 
further validated; Nevertheless its correlation with parameters of exercise capacity and DH 
is in accordance with published literature,(Vassaux et al., 2008; Tzani et al., 2011) which 
strengthens the rationale of its use.  
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In conclusion, this study indicated that patients with homogeneous emphysema 
hyperinflate significantly more during maximum exercise compared to the ones with 
heterogeneous emphysema. Upper lobe predominance was also associated with less DH 
and with a higher peak VO2, peak VO2/HR and peak RR; however no CPET parameter was 
found to be different between the groups, probably due to the significant but not vast 
difference in ΔIC% and the relatively small size of homogeneous group. Based on these 
findings, the primary null hypothesis is rejected, but the secondary null hypothesis is not. 
Lung hyperinflation has been associated with adverse disease outcomes and thus, several 
medical treatments, particularly bronchodilator therapy and invasive interventions have 
targeted on its improvement.(Gagnon et al., 2014)(Puente-Maestu & Stringer, 
2006)(Sanguinetti, 2014) However, apart from LVR procedures, almost no other 
therapeutic application has guided patient selection according to emphysema 
heterogeneity. This study strengthens the case that CT pattern of emphysema distribution 
should be taken under consideration in designing such interventional protocols and 
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I. Identification (registry) numbers for the clinical trials whose participants were 
included in the current study 
 
A) Bronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for Emphysema 
clinical study 
-Clinical Trials code number: NCT01727037 
 
B) Lung Volume Reduction Coil for Treatment in Patients With Emphysema (RENEW) 
Study 
-Clinical Trials code number: NCT01608490 
 
 C) Endobronchial Valves for Emphysema Palliation Trial (VENT) 
-Clinical Trials code number: NCT00129584 
 
D) Lung Volume Reduction Surgery (LVRS) study 
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II. The Modified Borg Dyspnea Scale (Burdon et al., 1982) 
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